Immatics (IMTX) FCF Payout Ratio (QoQ) (2019 - 2025)
Immatics (IMTX) FCF Payout Ratio (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 89.38% |
| Sep 30, 2025 | -389.73% |
| Jun 30, 2025 | 95.30% |
| Mar 31, 2025 | -831.87% |
| Dec 31, 2024 | 16.63% |
| Sep 30, 2024 | 14.77% |
| Jun 30, 2024 | 77.39% |
| Sep 30, 2022 | 956.42% |
| Jun 30, 2022 | -84.11% |
| Mar 31, 2022 | 88.67% |
| Dec 31, 2021 | 2,263.51% |
| Sep 30, 2021 | -102.95% |
| Jun 30, 2021 | 115.61% |
| Mar 31, 2021 | -1,683.82% |
| Dec 31, 2020 | 115.98% |
| Sep 30, 2020 | -390.10% |
| Jun 30, 2020 | 87.71% |
| Mar 31, 2020 | -2,174.28% |
| Dec 31, 2019 | -69.42% |